Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Vyxeos
Vyxeos
Jazz’s Vyxeos rollout hit a wall in Q3. What’s the holdup?
Fierce Pharma
Wed, 11/7/18 - 10:39 pm
Jazz Pharmaceuticals
Vyxeos
Jazz hiring 100-plus sales representatives to prep for new narcolepsy and AML launches
Fierce Pharma
Mon, 08/20/18 - 11:46 am
Jazz Pharmaceuticals
hirings
drug reps
solriamfetol
narcolepsy
Europe
Vyxeos
AML
FDA approves Jazz Pharmaceuticals’ liposomal AML chemotherapy
Drug Delivery Business News
Tue, 08/8/17 - 10:05 am
FDA
Jazz Pharmaceuticals
liposomal chemotherapy
Vyxeos
AML
Jazz nabs early FDA nod for AML med Vyxeos. Is diversifying M&A next?
Fierce Pharma
Thu, 08/3/17 - 09:49 pm
Jazz Pharmaceuticals
FDA
AML
Vyxeos
M&A
3 Reasons Jazz Pharmaceuticals Stock Could Fall
Motley Fool
Sun, 06/18/17 - 11:38 pm
Jazz Pharmaceuticals
Vyxeos
Xyrem
FDA slams drug maker for touting unapproved leukemia treatment to docs
Stat/Pharmalot
Wed, 09/7/16 - 11:55 am
FDA
Celator
off-label
Vyxeos
acute myeloid leukemia
Jazz Pharmaceuticals Agrees to Buy Celator for $1.5 Billion
Bloomberg
Tue, 05/31/16 - 09:18 am
Jazz Pharmaceuticals
Celator
M&A
Vyxeos
Celator Pharmaceuticals Nabs a Key FDA Designation, Readies for 2017
Motley Fool
Thu, 05/19/16 - 10:14 pm
Celator Pharmaceuticals
FDA
Vyxeos
AML
acute myeloid leukemia
3 Risky Biotechs With FDA Decisions On Deck
Motley Fool
Fri, 05/13/16 - 10:08 am
FDA
Sarepta Therapeutics
eteplirsen
Synergy Pharmaceuticals
plecanatide
Celator
Vyxeos
8 Major Biopharma Events Coming Later in 2016 and in 2017
24/7 Wall St
Tue, 03/29/16 - 10:33 pm
Vertex Pharmaceuticals
VX-661
cystic fibrosis
Incyte
ruxolitinib
colorectal cancer
breast cancer
Ultragenyx
KRN23
osteomalacia
GW Pharma
Epidiolex
Puma Biotechnology
neratinib
Celator Pharmaceuticals
Vyxeos
Biocryst
OPuS-2
BCX7353
HAE
Galena Biopharma
NeuVax
trastuzumab